Abrogation of cyclin D1 expression predisposes lung cancer cells to serum deprivation-induced apoptosis.
暂无分享,去创建一个
David Warburton | Lora Barsky | D. Warburton | K. Weinberg | B. Driscoll | S. Buckley | K. Anderson | L. Barsky | Kenneth Weinberg | Barbara Driscoll | Susan Buckley | Kathryn D Anderson
[1] D. Leroith,et al. Insulin-like Growth Factor 1 Inhibits Apoptosis Using the Phosphatidylinositol 3′-Kinase and Mitogen-activated Protein Kinase Pathways* , 1997, The Journal of Biological Chemistry.
[2] D. S. Henderson,et al. Chromosome fragmentation resulting from an inability to repair transposase-induced DNA double-strand breaks in PCNA mutants of Drosophila. , 1998, Mutagenesis.
[3] I. Weinstein. Relevance of cyclin D1 and other molecular markers to cancer chemoprevention , 1996, Journal of cellular biochemistry. Supplement.
[4] R. Baserga,et al. Insulin-like growth factor I (IGF-I) and the IGF-I receptor prevent etoposide-induced apoptosis. , 1995, Cancer research.
[5] Junying Yuan,et al. Suppression of Interleukin-1-converting Enzyme-mediated Cell Death by Insulin-like Growth Factor (*) , 1996, The Journal of Biological Chemistry.
[6] E. Wang,et al. Cells en route to apoptosis are characterized by the upregulation of c‐fos, c‐myc, c‐jun, cdc2, and RB phosphorylation, resembling events of early cell‐cycle traverse , 1995, Journal of cellular biochemistry.
[7] J. Hurwitz,et al. Inhibition of Nucleotide Excision Repair by the Cyclin-dependent Kinase Inhibitor p21 (*) , 1995, The Journal of Biological Chemistry.
[8] D. Lane,et al. Tumour suppressors, kinases and clamps: How p53 regulates the cell cycle in response to DNA damage , 1995, BioEssays : news and reviews in molecular, cellular and developmental biology.
[9] D. Warburton,et al. Apoptosis and DNA damage in type 2 alveolar epithelial cells cultured from hyperoxic rats. , 1998, American journal of physiology. Lung cellular and molecular physiology.
[10] B. Stewart. Mechanisms of apoptosis: integration of genetic, biochemical, and cellular indicators. , 1994, Journal of the National Cancer Institute.
[11] J. Greenberger,et al. Inhibition of G1-phase arrest induced by ionizing radiation in hematopoietic cells by overexpression of genes involved in the G1/S-phase transition. , 1995, Radiation research.
[12] H. Manev,et al. Removal of serum from primary cultures of cerebellar granule neurons induces oxidative stress and DNA fragmentation: Protection with antioxidants and glutamate receptor antagonists , 1996, Journal of neuroscience research.
[13] P. Burgers,et al. A mutational analysis of the yeast proliferating cell nuclear antigen indicates distinct roles in DNA replication and DNA repair , 1995, Molecular and cellular biology.
[14] Hui Zhang,et al. D type cyclins associate with multiple protein kinases and the DNA replication and repair factor PCNA , 1992, Cell.
[15] D. Vaux,et al. The role of the bcl-2/ced-9 gene family in cancer and general implications of defects in cell death control for tumourigenesis and resistance to chemotherapy. , 1997, Biochimica et biophysica acta.
[16] Y. Yamauchi,et al. Apoptosis was promoted at a nonpermissive temperature in DNA replication-defective temperature-sensitive mutants of mouse FM3A cells. , 1998, Experimental cell research.
[17] S. Fukushima,et al. Reversibility and apoptosis in rat urinary bladder papillomatosis induced by uracil. , 1997, Carcinogenesis.
[18] M. Korc,et al. Inhibition of basal and mitogen-stimulated pancreatic cancer cell growth by cyclin D1 antisense is associated with loss of tumorigenicity and potentiation of cytotoxicity to cisplatinum. , 1998, The Journal of clinical investigation.
[19] C J Kemp,et al. The role of p53 in spontaneous and radiation-induced apoptosis in the gastrointestinal tract of normal and p53-deficient mice. , 1994, Cancer research.
[20] D. Voehringer,et al. Bcl-2 expression causes redistribution of glutathione to the nucleus. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[21] C. Cordon-Cardo. Mutations of cell cycle regulators. Biological and clinical implications for human neoplasia. , 1995, The American journal of pathology.
[22] I. Schieren,et al. Antisense to cyclin D1 inhibits growth and reverses the transformed phenotype of human esophageal cancer cells. , 1995, Oncogene.
[23] A. Levine,et al. Cyclin D1 and p21/waf1 are both involved in p53 growth suppression. , 1996, Oncogene.
[24] R. Wood,et al. Mammalian DNA nucleotide excision repair reconstituted with purified protein components , 1995, Cell.
[25] R. Furlanetto,et al. Insulin-like growth factor-I induces cyclin-D1 expression in MG63 human osteosarcoma cells in vitro. , 1994, Molecular endocrinology.
[26] H. Geerts,et al. Okadaic Acid‐Induced Apoptosis in Neuronal Cells: Evidence for an Abortive Mitotic Attempt , 1998, Journal of neurochemistry.
[27] Y. Doki,et al. Increased expression of cyclin D1 in a murine mammary epithelial cell line induces p27kip1, inhibits growth, and enhances apoptosis. , 1996, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.
[28] John Calvin Reed,et al. R-Ras promotes apoptosis caused by growth factor deprivation via a Bcl- 2 suppressible mechanism , 1995, The Journal of cell biology.
[29] G. Powis,et al. Redox signalling and the control of cell growth and death. , 1995, Pharmacology & therapeutics.
[30] C. Sherr. Cancer Cell Cycles , 1996, Science.
[31] P. Hinds,et al. Inhibition of p53-mediated growth arrest by overexpression of cyclin-dependent kinases , 1996, Molecular and cellular biology.
[32] B. van der Burg,et al. Mitogenic Signaling of Insulin-like Growth Factor I in MCF-7 Human Breast Cancer Cells Requires Phosphatidylinositol 3-Kinase and Is Independent of Mitogen-activated Protein Kinase* , 1997, The Journal of Biological Chemistry.
[33] E. Wang,et al. Up‐regulated P21CIP1 expression is part of the regulation quantitatively controlling serum deprivation‐induced apoptosis , 1997, Journal of cellular biochemistry.
[34] Y. Doki,et al. Antisense to cyclin D1 inhibits the growth and tumorigenicity of human colon cancer cells. , 1997, Cancer research.
[35] Z. Oltvai,et al. Bcl-2 functions in an antioxidant pathway to prevent apoptosis , 1993, Cell.
[36] S. Shurtleff,et al. Overexpression of mouse D-type cyclins accelerates G1 phase in rodent fibroblasts. , 1993, Genes & development.
[37] D. Schrump,et al. Inhibition of lung cancer proliferation by antisense cyclin D. , 1996, Cancer gene therapy.
[38] A. K. Merchant,et al. Expression of wild-type p53 stimulates an increase in both Bax and Bcl-xL protein content in HT29 cells. , 1996, Oncogene.
[39] R. Sclafani,et al. Cyclin D1 overexpression vs. retinoblastoma inactivation: implications for growth control evasion in non-small cell and small cell lung cancer. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[40] W. Anderson,et al. Retroviral vector-mediated gene transfer of antisense cyclin G1 (CYCG1) inhibits proliferation of human osteogenic sarcoma cells. , 1995, Cancer research.
[41] M. Czaja,et al. c‐myc‐dependent hepatoma cell apoptosis results from oxidative stress and not a deficiency of growth factors , 1997, Journal of cellular physiology.
[42] E. White,et al. Life, death, and the pursuit of apoptosis. , 1996, Genes & development.
[43] G. Hannon,et al. Subcellular distribution of p21 and PCNA in normal and repair-deficient cells following DNA damage , 1996, Current Biology.
[44] L. Ellerby,et al. Shift of the Cellular Oxidation‐Reduction Potential in Neural Cells Expressing Bcl‐2 , 1996, Journal of neurochemistry.
[45] R. Weinberg,et al. Function of a human cyclin gene as an oncogene. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[46] S. Orrenius,et al. Signalling mechanisms and oxidative stress in apoptosis. , 1995, Toxicology letters.
[47] D. Housman,et al. Abrogation of oncogene-associated apoptosis allows transformation of p53-deficient cells. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[48] R. Radulescu. The 'LXCXE' hydropathic superfamily of ligands for retinoblastoma protein: a proposal. , 1995, Medical hypotheses.
[49] Y. Kaneko,et al. Apoptosis and nuclear levels of p53 protein and proliferating cell nuclear antigen in human hepatoma cells cultured with tumor promoters. , 1995, Cancer letters.
[50] D. Warburton,et al. Cyclin D1 antisense RNA destabilizes pRb and retards lung cancer cell growth. , 1997, American journal of physiology. Lung cellular and molecular physiology.
[51] Y. Liu,et al. Regulation of cyclin D1, DNA topoisomerase I, and proliferating cell nuclear antigen promoters during the cell cycle. , 1995, Gene expression.
[52] W. El-Deiry. Role of oncogenes in resistance and killing by cancer therapeutic agents. , 1997, Current opinion in oncology.
[53] C. Dive. Avoidance of apoptosis as a mechanism of drug resistance , 1997, Journal of internal medicine. Supplement.
[54] S. Estus,et al. Analysis of cell cycle-related gene expression in postmitotic neurons: Selective induction of cyclin D1 during programmed cell death , 1994, Neuron.
[55] Y. Sofer-Levi,et al. Apoptosis induced by ectopic expression of cyclin D1 but not cyclin E. , 1996, Oncogene.